China Pharma Holdings, Inc. revenue
China Pharma Holdings, Inc.'s revenue was $4.1m in fiscal 2025, down 8.5% on the year before. Since fiscal 2010 ($74.4m) it has grown at a compound -17.5% a year. Over the last twelve months it was $3.9m.
Revenue history
| Fiscal year | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74 | 81 | 55 | 33 | 22 | 20 | 16 | 13 | 12 | 11 | 11 | 10 | 8 | 7 | 5 | 4 | 4 |
| Growth on the year before | — | +9.1% | −32.8% | −39.8% | −32.5% | −8.1% | −23.5% | −15.1% | −6.7% | −11.4% | −0.5% | −11.3% | −15.9% | −13.5% | −35.4% | −8.5% | — |
| Gross profit | 30 | 29 | 14 | −0 | 3 | 1 | 3 | 2 | 2 | 1 | 2 | 0 | −0 | −0 | −2 | −0 | 0 |
| Gross margin | 40.7% | 35.7% | 25.8% | −1.5% | 12.1% | 7.2% | 20.7% | 18.7% | 16.0% | 13.6% | 18.0% | 3.6% | −6.1% | −4.0% | −43.8% | −3.2% | 11.8% |
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| China Pharma Holdings, Inc. | $3.9m | -11.0% | -21.0% |
| Therapeuticsmd, Inc. | $3.3m | 27.8% | -63.9% |
| Eyepoint, Inc. | $2.8m | -94.6% | -57.9% |
| Nutriband Inc. | $1.6m | -37.3% | -10.8% |
| Lipocine Inc. | $1.6m | -62.7% | 205.6% |
| China SXT Pharmaceuticals, Inc. | $1.1m | -34.6% | — |
Compare with peers
- Therapeuticsmd, Inc. revenue
- Eyepoint, Inc. revenue
- Nutriband Inc. revenue
- Lipocine Inc. revenue
- China SXT Pharmaceuticals, Inc. revenue
Head to head: CPHI vs TXMDCPHI vs EYPTCPHI vs NTRB
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies